Royal Bank Of Canada Incyte Corp Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Incyte Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 168,408 shares of INCY stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,408

Previous 144,457 16.58%

Holding current value

$12.5 Million

Previous $8.76 Million 27.12%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $1.37 Million - $1.64 Million	23,951 Added 16.58%	168,408 $11.1 Million
Q2 2024 Nov 06, 2024	SELL	$51.18 - $63.75 $255,439 - $318,176	-4,991 Reduced 3.34%	144,457 $8.76 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $22.7 Million - $28.3 Million	-444,072 Reduced 74.82%	149,448 $9.06 Million
Q1 2024 Nov 05, 2024	BUY	$56.55 - $66.59 $22.4 Million - $26.4 Million	396,531 Added 265.33%	545,979 $31.1 Million
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $5.06 Million - $5.96 Million	-89,452 Reduced 13.1%	593,520 $33.8 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $15.9 Million - $19.5 Million	-304,080 Reduced 30.81%	682,972 $42.9 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $26.3 Million - $30 Million	454,416 Added 85.31%	987,052 $57 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $740 Million - $916 Million	-12,135,260 Reduced 95.8%	532,636 $33.2 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $227 Million - $278 Million	3,227,163 Added 34.18%	12,667,896 $916 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $15.7 Million - $19.7 Million	233,882 Added 2.54%	9,440,733 $758 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $3.72 Million - $4.66 Million	56,188 Added 0.61%	9,206,851 $614 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $97.1 Million - $122 Million	1,467,911 Added 19.11%	9,150,663 $695 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $274 Million - $331 Million	4,148,559 Added 117.38%	7,682,752 $610 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $21.2 Million - $24.8 Million	334,737 Added 10.46%	3,534,193 $259 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $46 Million - $56.3 Million	669,958 Added 26.49%	3,199,456 $220 Million
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $202 Million - $221 Million	2,529,498 New	2,529,498 $213 Million

Others Institutions Holding INCY

# of Institutions

657

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Incyte Corp Transaction History